Quantcast

Latest Immunity Stories

Reasons For Measles High-Contagiousness Pinpointed
2011-11-05 04:59:44

An international team of researchers say that they have discovered how and why the measles virus spreads so quickly -- respiratory secretions linked to a key receptor located in the trachea. In a Friday press release, officials with INSERM (Institut national de la santé et de la recherche médicale), who was involved with the work, report that this receptor, known as nectine-4, "allows the virus to spread through the air rapidly from one organism to another."...

2011-07-11 20:11:58

Researchers at the Emory Vaccine Center have developed a method for predicting whether someone will produce high levels of antibodies against a flu shot a few days after vaccination. After scanning the extent to which carefully selected genes are turned on in white blood cells, the researchers can predict on day three, with up to 90 percent accuracy, who will make high levels of antibodies against a standard flu shot four weeks later. The results were published online July 10 in the journal...

2011-07-05 06:58:56

(Ivanhoe Newswire) -- A new class of therapeutics, known as recombinant attenuated Salmonella vaccines (RASV), may fight against fatal diseases such as hepatitis B, tuberculosis, cholera, typhoid fever, AIDS and pneumonia, according to a new study. Researchers from Arizona State University have developed a way to make these vaccines safer and more effective. They demonstrated that a modified strain of Salmonella showed a five-fold reduction in virulence in mice, while preserving strong...

2011-06-08 15:58:06

Killer T Cells Activated to Bring Extra Protection Researchers at National Jewish Health have discovered how to prime a second arm of the immune system to potentially boost influenza vaccine effectiveness. A combination of two adjuvants, chemicals used to boost the effectiveness of some vaccines, induced CD8, or killer, T cells to join antibodies in response to influenza infection. Since the killer T cells targeted a highly conserved protein that does not change from year to year, the...

2011-05-17 18:00:00

KING OF PRUSSIA, Pa., May 17, 2011 /PRNewswire/ -- CSL Behring, a global biotherapeutics company specializing in plasma-derived and recombinant therapies and a subsidiary of CSL Limited (ASX: CSL), is a recipient of the National Organization for Rare Disorders (NORD) 2011 Corporate Award. The award was presented this evening at the NORD Partners in Progress Celebration 2011 for "new treatments brought to market for patients with rare diseases." (Logo:...

2011-04-12 11:00:47

Nasal vaccines that effectively protect against flu, pneumonia and even bioterrorism agents such as Yersinia pestis that causes the plague, could soon be a possibility, according to research presented at the Society for General Microbiology's Spring Conference in Harrogate. Professor Dennis Metzger describes how including a natural immune chemical with standard vaccines can boost their protective effect when delivered through the nose. The respiratory tract is a major entry site for various...

2011-02-28 22:20:43

New research that reveals how maternal antibodies block an immune response to the measles virus is a first step toward improving current childhood vaccination practices, scientists say. Maternal antibodies are passed to fetuses during pregnancy and to newborns in their mothers' milk. The antibodies protect infants against disease in the first months of life, but that protection comes at a cost: Their presence also interferes with the generation of a natural immune response to vaccination. As...

243827436ba4287e621c00f5ca52713e1
2011-01-25 06:05:00

Scientists suggest that man flu is not a myth, after finding they suffer more because they invest in their spirit of adventure at the expense of their immune system. Men's ability to turn a sniffle into the flu and a headache into a migraine has long been a source of annoyance to their better halves, reports The Daily Telegraph. But according to the new research, there could be proof that they are not faking it, and that they suffer diseases more seriously and for longer. Scientists...

2010-09-02 07:00:00

PRINCETON, N.J., Sept. 2 /PRNewswire-FirstCall/ -- Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company, announced today the publication of an article online in Vaccine. The article describes the systematic identification of neutralizing and non-neutralizing B-cell epitopes on ricin toxin's enzymatic A subunit (RTA). An inactivated form of RTA is the primary component of RiVax(TM), the Company's proprietary vaccine against ricin...

2010-05-14 07:00:00

SANTA BARBARA, Calif., May 14 /PRNewswire/ -- Direct Relief International announced today that CSL Behring has donated life-saving medicines valued at more than $100,000 to assist earthquake victims in Haiti who are at risk of tetanus or hepatitis B infections. The products will be used in clinics at Hopital Albert Schweitzer in Deschapelles. The donation, consisting of 5,000 syringes of Tetagam® P and 600 5ml ampoules of Hepatitis B Immunoglobulin, will help treat...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related